News and Trends 31 Mar 2025
AstraZeneca bets on Asia: a surge of deals in March amid fraud probe
AstraZeneca has vowed to spend over $10 billion in Asia, particularly in China, to build Beijing into an R&D hub amid probe into fraud scandals.
Partnerships
- Latest Posts
Best in Biotech 27 Mar 2025
12 AI drug discovery companies you should know about
Take a look at 12 of the top AI drug discovery companies around today, using their technology to speed up the drug discovery process.
News and Trends 25 Mar 2025
AbbVie and Genmab: Can a legal battle break a billion-dollar bond?
As AbbVie accuses Genmab of unlawfully using proprietary ADC technology, find out about their collaboration and the dispute opposing them.
In Depth 19 Mar 2025
Breast cancer treatments heat up: Five therapies poised to transform patient outcomes
Find out more about the overall breast cancer treatment landscape, as biotech companies make progress with different approaches.
In Depth 7 Mar 2025
Catalonia: A biotech hub going from strength to strength, with Barcelona at its core
Take a deeper look at Catalonia’s biotech sector and overall life sciences hub, including the key drivers behind its success.
News and Trends 6 Mar 2025
Top biotech deals of February 2025
Find out about the top biotech partnership deal of February 2025. Small molecules, T-cell engagers, and RNA medicines, were all part of major collaborations.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 5 Mar 2025
Seven biotech companies keeping Taiwan dynamic in 2025
Discover 7 biotech companies in Taiwan, a rising regional player in precision medicine, immunotherapy, and drug development, backed by strong research and government support.
Best in Biotech 27 Feb 2025
Eight respiratory disease companies advancing innovative therapies in 2025
Discover eight respiratory disease companies advancing their novel therapies through clinical trials in 2025.
News and Trends 24 Feb 2025
Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree?
This year has seen Eli Lilly sign several licensing deals to bolster its position across a range of therapeutic areas amid growing drug revenues.
News and Trends 19 Feb 2025
Trade war: how new U.S. tariffs will impact the biopharma industry
The U.S. plans to impose trade tariffs on imports. How does this affect the biopharma industry?
In Depth 18 Feb 2025
T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments
T cell engagers represent a novel approach to tuning the immune system to target and kill tumor cells, expanding treatment options for cancer.
Partnering 2030: FME Industries Report
Download Inpart’s new report to discover key challenges in the Food, Material, and Electromechanical (FME) industries, the best channels for sourcing new partners, and a ranking of the top companies in industry-academia partnerships.
ADVERTISEMENT
